Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 2911-2921

  Mal, Asoke ^a   Piotrkowski, Anthony ^a   Harter, Marian L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; VIRUS DNA;

ADENOVIRUS; ARTICLE; DNA PROTEIN COMPLEX; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0029876717     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.2911-2921.1996     Document Type: Article

References (122)

1. Abraham, S. E., S. Lobo, P. Yaciuk, H.-G. H. Wang, and E. Moran. 1993. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8:1639-1647.
2. 1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:9571-9575.
3. Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and R. Eckner. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (London) 374:81-84.
4. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217.
5. Bagchi, S., P. Raychaudhuri, and J. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659-669.
6. Banerjee, A. C., A. J. Recupero, A. Mal, A. M. Piotrkowski, D.-M. Wang, and M. L. Harter. 1994. The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300. Oncogene 9:1733-1737.
7. Barbeau, D., R. Charbonneau, S. G. Wahlen, S. T. Bayley, and P. E. Branton. 1994. Functional interactions within adenovirus E1A protein complexes. Oncogene 9:359-373.
8. Barik, S. 1993. Expression and biochemical properties of a protein serine/ threonine phosphatase encoded by bacteriophage. Proc. Natl. Acad. Sci. USA 90:10633-10637.
9. 1 cyclin complexes. Genes Dev. 9:1340-1353.
10. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
11. Caruso, M., F. Martelli, A. Giordano, and A. Felsani. 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8:267-278.
12. Chatterjee, P. K., and S. J. Flint. 1986. Partition of E1A proteins between soluble and structural fractions of adenovirus-infected and -transformed cells. J. Virol. 60:1018-1026.
13. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
14. Claudio, P. P., C. M. Howard, A. Baldi, A. De Luca, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano. 1995, p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54:5556-5560.
15. Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol Chem. 252:1102-1106.
16. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
17. Datta, S., C. J. Soong, D. M. Wang, and M. L. Harter. 1991. A purified adenovirus 289-amino-acid E1A protein activates RNA polymerase III transcription in vitro and alters transcription factor TFIIIC. J. Virol. 65: 5297-5304.
18. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14:5441-5449.
19. Dobrowolski, S. F., D. W. Stacey, M. L. Harter, J. T. Stine, and S. W. Hiebert. 1994. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9:2605-2612.
20. Dou, Q.-P., A. H. Levin, S. Zhao, and A. B. Pardee. 1993. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53: 1493-1497
21. Dowdy, S. F., P. W. Hinds, K. Louie, S. L Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins Cell 73:499-511.
22. 1-S phase protein kinase. Science 257:1958-1961.
23. Dumont, D. J., and P. E. Branton. 1992. Phosphorylation of adenovirus E1A proteins by the p34cdc2 protein kinase. Virology 189:111-120
24. Dumont, D. J., R. C. Marcellus, S. T. Bayley, and P. E. Branton. 1993 Role of phosphorylation near the amino terminus of adenovirus type 5 early region 1A proteins. J. Gen. Virol. 74:583-595.
25. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes Genes Dev. 8:1772-1786.
26. Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249-255.
27. Dyson, N., P. Guida, C. McCall, and E. Harlow. 1992. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J. Virol. 66: 4606-4611.
28. Dyson, N., and E. Harlow. 1992. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12:161-195.
29. Engstrom, L., P. Ekman, E. Humble, U. Ragnarsson, and O. Zetterqvist. 1984. Detection and identification of substrates for protein kinases: use of proteins and synthetic peptides. Methods Enzymol. 107:130-154.
30. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
31. Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
32. Faha, B., M. E. Ewen, L.-H. Tsai, D. M. Livingston, and E. Harlow. 1992. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255:87-90.
33. cdk2. J. Virol. 67:2456-2465.
34. Fanning, E. 1992. Simian virus 40 large T antigen: the puzzle, the pieces. and the emerging picture. J. Virol. 66:1289-1293.
35. Fattaey, A. R., E. Harlow, and K. Helin. 1993. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13:7267-7277.
36. Fischer, S. G. 1983. Peptide mapping in gels. Methods Enzymol. 100:424-430.
37. Giordano, A., P. Whyte, E. Harlow, B. E. Franza, Jr., D. Beach, and G. Draetta. 1989. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell 58:981-990.
38. Graham, F. O., J. Smiley, W. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
39. Harlow, E., B. R. Franza, Jr., and C. Schley. 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Virol. 55:533-546
40. Harlow, E., P. Whyte, B. R. Franza, Jr., and C. Schley. 1986. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 6:1579-1589.
41. Harter, M. L., and J. B. Lewis. 1978. Adenovirus, type 2 early proteins synthesized in vitro and in vivo: identification in infected cells of the 38,000-to 50,000-molecular-weight protein encoded by the left end of the adenovirus type 2 genome. J. Virol. 26:736-749.
42. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508.
43. Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1850-1861.
44. suc1, examined in living cells. Proc. Natl. Acad. Sci. USA 91:2176-2180.
45. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
46. Horton, L. E., Y. Qian, and D. J. Templeton. 1995. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth Differ. 6:395-407.
47. Howe, J. A., J. S. Mymryk, C. Egan, P. E. Branton, and S. T. Bayley. 1990. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc. Natl. Acad. Sci. USA 87:5883-5887.
48. 1/S-phase growth arrest. Mol. Cell. Biol. 11:1185-1194.
49. Hu, Q. J., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9:1147-1155.
50. Hunter, T. 1993. Braking the cycle. Cell 75:839-841.
51. Hunter, T., and J. Pines. 1994. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79:573-582
52. Ikeda, M.-A., and J. R. Nevins. 1993. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13:7029-7035.
53. Kaelin, W. G., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen-and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol 10:3761-3769.
54. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
55. Kato, J.-Y., M. Matsuoka, D. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713-2721.
56. Kitagawa, M. H. Higashi, I. Suzuki-Takahashi, K. Segawa, S. K. Hanks, U. Taya, S. Nishimura, and A. Okuyama. 1995. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene 10:229-236.
57. Kleinberger, T. and T. Shenk. 1991. A protein kinase is present in a complex with adenovirus E1A proteins. Proc. Natl. Acad. Sci USA 88: 11143-11147.
58. 1 phase of the human cell cycle. Science 257:1689-1693
59. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, Jr., and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172. (Abstract.)
60. Laemmli, U. K. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
61. La Thangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108-114.
62. Lee, J.-S., K. M. Galvin, R. H. See, R. Eckner, D. Livingston, E. Moran, and Y. Shi. 1995. Retief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 9:1188-1198.
63. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1885.
64. Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
65. Lucher, L. A., P. M. Loewenstein, and M. Green. 1985. Phosphorylation in vitro of Escherichia coli-produced 235R and 266R tumor antigens encoded by human adenovirus type 12 early transformation region 1A. J Virol. 56:183-193.
66. Ludlow, J. W., and G. R. Skuse. 1995 Viral oncoprotein binding to pRb. p107, p130, and p300. Virus Res. 35:113-121.
67. Lundblad, J. R., R. P. S. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated p300 is a functional homologue of the transcriptional co-activator CBP. Nature (London) 374:85-88.
68. 67a.Mal. A. Unpublished data.
69. Mal, A., and M. L. Harter. Unpublished data.
70. Kip1 in TGF-β treated cells. Nature (London), in press.
71. PSK-J3/cdk4) for mammalian D type G1 cyclins Cell 71:323-334.
72. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato. 1994, D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076
73. McVey, D., L. Brizuela, I. Mohr, D. R. Marshak, and Y. Gluzman. 1989. Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication. Nature (London) 341:503-507
74. Meyerson, M., G. H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. Nelson, E. Harlow, and L.-H. Tsai. 1992. A family of human cdc2-related protein kinases EMBO J. 11:2909-2917.
75. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol 14:2077-2086
76. 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc. Natl. Acad. Sci. USA 88:3489-3493.
77. Moodie, S. A., B. M. Willumsen, M. J. Weber, and A. Wolfman. 1993. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260:1658-1661.
78. Moran, E. 1994 Cell growth control mechanisms reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol 5:327-340.
79. Muller, R. 1995. Transcriptional regulation during the mammalian cell cycle. Trends Genet. 11:173-178
80. Muller, R., D. Mumberg, and F. C. Lucibello. 1993. Signals and genes in the control of cell-cycle progression. Biochim. Biophys. Acta 1155:151-179
81. Nevins, J. R. 1993. Disruption of cell-cycle control by viral oncoproteins. Biochem. Soc. Trans. 21:935-938
82. 1 in mammalian fibroblasts. Science 259:1908-1912.
83. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
84. Pines, J., and T. Hunter. 1990. p34cdc2. the S and M kinase New Biol. 2:389-401.
85. Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associ ated protein p60 and behaves differently from cyclin B. Nature (London) 346:760-763.
86. cdc2. EMBO J. 12:3123-3132
87. M015. J. Cell Sci. 107:2789-2799.
88. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
89. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
90. Raychaudhure, P., S. Bagchi, S. H. Devoto, V. B. Kraus, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200-1211
91. Richter, J. D., J. M. Slavicek, J. F. Schneider, and N. C. Jones. 1988. Heterogeneity of adenovirus type 5 E1A proteins: multiple serine phosphorylations induce slow-migrating electrophoretic variants but do not affect E1A-induced transcriptional activation or transformation. J. Virol. 62:1948-1955.
92. Roach, P. J. 1991. Multisite and hierarchal protein phosphorylation. J Biol. Chem. 266:14139-14142.
93. 2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89:2824-2828.
94. Ruderman, J. V. 1993. MAP kinase and the activation of quiescent cells. Curr. Opin. Cell Biol. 5:207-213. (Review.)
95. cdc2 kinase in G1 phase of the HeLa cell division cycle. J. Biol. Chem. 267:20317-20325.
96. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response EMBO J. 12:1013-1020.
97. Shenk, T., and J. Flint. 1991. Transcriptional and transforming activities of the adenovirus E1A proteins Adv Cancer Res. 57:47-85.
98. 1 cyclins. Cell 73:1059-1065.
99. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
100. Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187-190
101. Smith, C. L., C. Debouck, M. Rosenberg, and J. S. Culp. 1989 Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function. J. Virol. 63:1569-1577.
102. Smith, D. H., and E. B. Ziff. 1988. The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Mol. Cell Biol 8:3882-3890.
103. Stabel, S., P. Argos, and L. Philipson. 1985. The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J. 4:2329-2336.
104. Stacey, D. W., S. F. Dobrowolski, A. Piotrkowski, and M. L. Harter. 1994. The adenovirus E1A protein overrides the requirement for cellular ras in initiating DNA synthesis. EMBO J. 13:6107-6114.
105. Traugh, J. A. 1989. Approaches to examine the role of multiple serine protein kinases in coordinate regulation of cell growth, p 173-202. In Advances in the regulation of cell growth. Raven, New York.
106. Tremblay, M. L., D. J. Dumont, and P. E. Branton. 1989. Analysis of phosphorylation sites in the exon 1 region of E1A proteins of human adenovirus type 5. Virology 169:397-407.
107. Tremblay, M. L., C. J. McGlade, G. E. Gerber, and P. E. Branton. 1988. Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments. J. Biol Chem. 263:6375-6383.
108. Vindelov, L. L., L. J. Christensen, and N. I. Nissen. 1983 A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327.
109. Wang, D.-M., B. Dalie, and M. L. Harter. 1992. The adenovirus E1A 243R protein purified from Escherichia coli under nondenaturing conditions is found in association with dnaK. Protein Expr. Purif. 3:8-17.
110. Wang, H.-G. H., Y. Rikitake, M. C. Carter, P. Yaciuk, S. E. Abraham, B. Zerler, and E. Moran. 1993. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and the control of cell growth. J. Virol. 67:476-488.
111. Webster, K. A., G. E. O. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (London) 332:553-557
112. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
113. Welch, P. J., and J. Y. J. Wang. 1992. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 89:3093-3097.
114. Whyte, P. K., K. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124-129.
115. Wu, C.-L, L. R. Zukerberg, C. Ngwu, E. Harlow, and J. A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15:2536-2546.
116. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
117. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572-1583.
118. Yaciuk, P., and E. Moran. 1991. Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol. Cell. Biol. 11:5389-5397.
119. Yee, S.-P., and P. E. Branton. 1985. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology 147:142-153.
120. Yee, S.-P., D. T. Rowe, M. L. Tremblay, M. McDermott, and P. E. Branton. 1983. Identification of human adenovirus early region 1 products using antisera against synthetic peptides corresponding to the predicted carboxy termini. J. Virol. 46:1003-1013.
121. Yu, I. J., D. L. Spector, Y.-S. Bae, and D. R. Marshak. 1991. Immunocytochemical localization of casein kinase II during interphase and mitosis. J. Cell Biol. 114:1217-1232.
122. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein Genes Dev. 7:1111-1125.